Emergent BioSolutions (EBS) Misses Q1 EPS by 1c, Reaffirms Guidance
Tweet
Share
E-mailGet Alerts EBS Hot Sheet
Price: $5.94 -0.5%
Financial Fact:
Weighted-average number of shares - diluted: 49.44M
Today's EPS Names:
VIVE, ENSV, MDLM, More
Financial Fact:
Weighted-average number of shares - diluted: 49.44M
Today's EPS Names:
VIVE, ENSV, MDLM, More
Join SI Premium – FREE
Emergent BioSolutions (NYSE: EBS) reported Q1 EPS of $0.29, $0.01 worse than the analyst estimate of $0.30. Revenue for the quarter came in at $116.9 million versus the consensus estimate of $116.17 million.
Emergent BioSolutions reaffirmed guidance.
For earnings history and earnings-related data on Emergent BioSolutions (EBS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- The Gap, Inc. (GAP) Tops Q2 EPS by 3c
- Marvell Technology (MRVL) Tops Q2 EPS by 1c, Offers Guidance
- SolarEdge (SEDG) PT Lowered to $31 at Jefferies, 'We see shares as an unappealing short, not a compelling long'
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
